A Phase 1b, Multicenter, Open-Label, Safety, Tolerability, and Activity Study of SYNT001 in Subjects with Chronic Pemphigus (Vulgaris or Foliaceus)
Clinical Trial Grant
Administered By
Dermatology
Awarded By
Syntimmune, Inc.
Start Date
July 27, 2017
End Date
April 22, 2020
Administered By
Dermatology
Awarded By
Syntimmune, Inc.
Start Date
July 27, 2017
End Date
April 22, 2020